Online ISSN: 2515-8260

Keywords : Amniotic fluid index


Maternal And Fetal Outcomes In Term Pregnancies With Decreased Amniotic Fluid

Dr. A. Manisha; Dr. Amardeep Tembhare

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 11, Pages 3584-3591

Background:Amniotic fluid isthe utmost important component of fetal wellbeing.It isalso an indicator of normal placental function.Amniotic fluid present within amniotic cavity,is described as clear,slightly yellowish liquid that surrounds the fetus during pregnancy.It is helpful inthe development of fetal respiratory , urinary , gastrointestinal andmusculoskeletal systems.It provides thermally controlled and a non-restricted sterileenvironment for fetal growth.
Aim:To study whether decreased amniotic fluid index (AFI) is a measureof adverse maternal and fetal outcomes in term pregnancy.
Objectives:
1)To estimate amniotic fluid at or >37 weeks by ultrasonography.
2)To observe the maternal and fetal outcomesat term withdecreased amniotic fluid and normal amniotic fluid.
Material and Method :The study will be conducted for two years .Data will be collected frompatients attending the department of Obstetrics and Gynecology in AVBRH attached to DMIMS ,Sawangi. After meeting selectioncriteria, based on AFI ,they will be further divided into 3 groups .Group A: includesthose with low amniotic fluid index(AFI<5 cm) Group B: includes those with borderline amniotic fluid index (AFI>5cm and <8cm)and Group C: includesnormal amniotic fluid index (AFI 8cm-24cm).Each group will be analysed and compared based on the ultrasonographic findings and feto-maternal outcome.
Expected Results : AFIlevels will be compared for their antenatal, intra-natal and postnatal maternal and fetal outcomes.Secondary outcomes like pregnancy outcome and neonatal wellbeing will be assessed. The desired outcome is to understand maternal and fetal outcomes in term women with decreased amniotic fluid comparedto normal amniotic fluid .
Conclusion:Due to expected adverse outcomes with decreased AFI antepartum surveillance is advised.

A COMPARATIVE STUDY OF THE EFFECT OF ORAL AMINO ACID SUPPLEMENTATION VS INTRAVENOUS AMINO ACID INFUSION ON AMNIOTIC FLUID INDEX AND PERINATAL OUTCOME IN PREGNANCIES COMPLICATED BY OLIGOHYDRAMNIOS AND FOETAL GROWTH RESTRICTION

Dr. AKRUTI SHINDE; Dr. MEHUL SALVE

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 7, Pages 2018-2026

BACKGROUND: The primary function of amniotic fluid is protection of the growing foetus while providing nutrition. A considerable amount of research has been conducted to evaluate interventions to improve amniotic fluid index and the subsequent impact on foetal growth restriction and oligohydramnios. However, there isn't any conclusive evidence hence this study aims to compare the effect of oral amino acid supplements and intravenous infusions in pregnancies with oligohydramnios and foetal growth restriction. 
AIM: To compare the effect of oral amino acid supplementation vs intravenous amino acid infusion on amniotic fluid index and perinatal outcome in pregnancy complicated by oligohydramnios and foetal growth restriction
OBJECTIVES: To compare the effectiveness of oral amino acid supplementation vs intravenous amino acid infusion in pregnancy having oligohydramnios and foetal growth restriction. To study the increase in amniotic fluid index in pregnancy with foetal weight gain. To study the interval growth rate of baby after two weeks and four weeks of therapy.
MATERIAL AND METHOD: This Semi experimental study will be conducted in Department of Obstetrics and Gynaecology, AVBRH, Datta Meghe Institute of Medical Sciences, Sawangi (Meghe), Wardha. A total of 104 clinically and sonographically proven cases of foetal growth restriction & Oligohydramnios in third trimester attending antenatal clinic or admitted in wards, fulfilling the exclusion and inclusion criteria will be comprise the study groups. After providing oral supplements or intravenous infusions arbitrarily, repeat ultrasonography will be done after two weeks and four weeks of therapy.
EXPECTED RESULTS: We compare from our results the effect of oral amino acid supplementation vs intravenous amino acid infusion on amniotic fluid index and perinatal outcome in pregnancies complicated by oligohydramnios and foetal growth restriction.